Loading decisions…
Loading decisions…
9,954 vetted Board decisions for Hepatitis C.
The Veteran's service-connected disabilities, including unspecified depressive disorder and peripheral neuropathy in all extremities, were granted with specific ratings. TDIU was also granted effective January 28, 2019.
The Board denied service connection for hepatitis C as the evidence did not support a current diagnosis of the condition.
The Board remands the matter to obtain outstanding private treatment records and confirm the date of the Veteran's Hepatitis C diagnosis, as well as to obtain a new VA opinion addressing the nature and etiology of the Veteran's Hepatitis C in light of his assertions regarding exposure during air gun inoculations and his reported risk factors.
The Board denied the veteran's claims for a compensable rating for hypertension, hepatitis C, and liver cirrhosis and gallstones. The claim for service connection for diabetes mellitus type II was remanded.
The Board denied the claims for service connection for a left foot great toe disability, hepatitis C, and pseudofolliculitis barbae, as well as initial compensable ratings for hammer toes of both feet and a total disability rating based on individual unemployability due to service-connected disabilities.
The Board denied the claim for service connection for the cause of the Veteran's death, finding that there was no evidence linking his medical conditions to his active service.
The Board granted a 100 percent rating for cirrhosis of the liver effective January 3, 2020, but denied earlier effective dates and higher ratings for both conditions.
The Board remands the claim for a medical opinion concerning whether the Veteran's cardiac arrhythmia, fatal liver disease, and hepatitis C were related to service.
The Board remands the claim for service connection for hepatitis C to correct pre-decisional duty to assist errors, including obtaining relevant non-VA treatment records and an adequate VA examination.
The Board denied the request to reopen the groin injury claim for lack of new and material evidence, denied service connection for bleeding of the colon on the merits, and remanded three issues (right shoulder condition, epididymitis, and the 38 U.S.C. § 1151 perforation claim) for further development after reopening the perforation claim based on newly received evidence.
The Board denied the Veteran's claims for service connection for hepatitis C and cirrhosis, finding that the evidence did not support a link between these conditions and his active service or his service-connected PTSD.
The Board remands the claims for service connection for hepatitis C, high blood pressure, a liver disability, and a cardiac disability due to insufficient evidence.
The Board granted service connection for cervical disc disease with radiculopathy, secondary to the Veteran's lumbar spine disability. The Board also granted ratings of 50%, 80%, and 40% for various neurological conditions affecting the lower extremities, as well as a rating of 60% for hepatitis C with cirrhosis of the liver.
The Board granted service connection for hepatitis C, finding that the evidence is at least in approximate balance that the Veteran's current hepatitis C disability was incurred in and is etiologically related to active service.
The Board remands the issues of service connection for hepatitis C, a respiratory disability, a low back disability, and a cervical spine disability, as well as higher ratings for the left knee and right ankle disabilities, due to inadequate medical opinions.
The Veteran has withdrawn the appeal for an initial compensable rating for hepatitis C, and the Board does not have jurisdiction to review this appeal.
The Board remands the claims for service connection for hepatitis C and liver cancer for readjudication due to new evidence.
The Board denied the Veteran's claim for service connection for Hepatitis C, finding that the evidence does not support a link between the condition and his military service.
The Board remands the claim for service connection for hepatitis C to obtain an addendum opinion addressing whether IV drug use without sharing needles is a risk factor for hepatitis C.
The Board denied increased ratings for the Veteran's right hip, varicose veins of the right leg, and hepatitis C, as the evidence did not support higher disability ratings.
← Back to Hepatitis C overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.